scispace - formally typeset
J

Juan I. Castrillo

Researcher at University of Cambridge

Publications -  32
Citations -  1633

Juan I. Castrillo is an academic researcher from University of Cambridge. The author has contributed to research in topics: Systems biology & Chemostat. The author has an hindex of 19, co-authored 27 publications receiving 1463 citations. Previous affiliations of Juan I. Castrillo include Delft University of Technology & University of Manchester.

Papers
More filters
Journal ArticleDOI

Growth control of the eukaryote cell: a systems biology study in yeast

TL;DR: This work constitutes a first comprehensive systems biology study on growth-rate control in the eukaryotic cell and has direct implications for advanced studies on cell growth, in vivo regulation of metabolic fluxes for comprehensive metabolic engineering, and for the design of genome-scale systems biology models of the eUKaryoticcell.
Journal ArticleDOI

An optimized protocol for metabolome analysis in yeast using direct infusion electrospray mass spectrometry.

TL;DR: A method for the global analysis of yeast intracellular metabolites, based on electrospray mass spectrometry (ES-MS), has been developed and may be used for comparative analysis and screening of metabolite profiles of yeast strains and mutants under controlled conditions in order to elucidate gene function via metabolomics.
Journal ArticleDOI

Regulation of alcoholic fermentation in batch and chemostat cultures of Kluyveromyces lactis CBS 2359.

TL;DR: It is concluded that in K. lactis, as in other Crabtree‐negative yeasts, the primary environmental trigger for occurrence of alcoholic fermentation is oxygen limitation.
Journal ArticleDOI

Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease.

Andrea Vergallo, +108 more
TL;DR: Blood‐based biomarkers of pathophysiological brain amyloid β (Aβ) accumulation, particularly for preclinical target and large‐scale interventions, are warranted to effectively enrich Alzheimer's disease clinical trials and management.